头颈癌患者第二原发肿瘤风险的系统综述
结果显示,在至少22个月随访下,SPT平均发生率为13.2%(95%CI: 11.56-14.84),其中同时性SPT为5.3%(95%CI: 4.24-6.36),异时性SPT为9.4%(95%CI: 7.9-10.9)。SPT最常见部位为头颈区域,其次为肺和食管。尽管研究间差异较大,但头颈癌患者SPT发生率较高,鉴于其对预后的影响,需制定早期诊断策略。
要点
- 头颈癌患者第二原发肿瘤平均发生率为13.2%。
- 同时性SPT发生率5.3%,异时性SPT发生率9.4%。
- SPT最常见于头颈区域,其次为肺和食管。
核心结论
- 头颈癌患者第二原发肿瘤发生率较高,研究间差异大,需制定早期诊断策略以改善预后。
主要发现
- 至少22个月随访下,SPT平均发生率为13.2%(95%CI: 11.56-14.84)。
- 同时性SPT发生率为5.3%(95%CI: 4.24-6.36),异时性SPT发生率为9.4%(95%CI: 7.9-10.9)。
- SPT最常见部位为头颈区域,其次为肺和食管。
关键数值与推荐
- SPT平均发生率13.2%(95%CI: 11.56-14.84)。
- 同时性SPT发生率5.3%(95%CI: 4.24-6.36),异时性SPT发生率9.4%(95%CI: 7.9-10.9)。
临床怎么用
- 头颈癌治疗后随访中应关注第二原发肿瘤的早期诊断,尤其头颈、肺和食管部位。
局限性
- 研究间SPT发生率存在较大差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Second primary tumors (SPTs) are a common cause of reduced life expectancy in patients treated for head and neck cancer (HNC). This phenomenon forms an area to be addressed during posttreatment follow-up. METHODS: We conducted a systematic review of literature following PRISMA guidelines, from 1979 to 2019, to investigate incidence of SPTs, synchronous, and metachronous, in HNC population. RESULTS: Our review includes data of 456 130 patients from 61 articles. With a minimum follow-up of 22 months, mean incidence of SPTs was 13.2% (95% CI: 11.56-14.84): 5.3% (95% CI: 4.24-6.36) for synchronous SPTs and 9.4% (95% CI: 7.9-10.9) for metachronous SPTs. The most frequent site for SPTs was head and neck area, followed by the lungs and esophagus. CONCLUSION: Although with wide variations between studies, the rate of SPTs in HNC patients is high. Given the impact in the prognosis, we must develop strategies for the early diagnosis of SPTs.
引用
- Coca-Pelaz A, Rodrigo JP, Suárez C, et al. The risk of second primary tumors in head and neck cancer: A systematic review. Head Neck. 2019. PMID: 31750595. doi:10.1002/hed.26016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。